Modernizing legacy data systems is no longer optional—it's the key to unlocking AI’s full potential with real-time insights, ...

In April 2025, the US Food and Drug Administration (FDA) published a roadmap for leveraging new approach methodologies (NAMs), including in silico approaches such as artificial intelligence (AI), to ...